• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Investig . Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia

tetano

Editor, Senior Moderator
Respir Investig


. 2020 Nov 23;S2212-5345(20)30160-X.
doi: 10.1016/j.resinv.2020.10.009. Online ahead of print.
Decrease in hemoglobin level predicts increased risk for severe respiratory failure in COVID-19 patients with pneumonia


Moriyasu Anai[SUP] 1 [/SUP], Kimitaka Akaike[SUP] 2 [/SUP], Hajime Iwagoe[SUP] 3 [/SUP], Takefumi Akasaka[SUP] 4 [/SUP], Takushi Higuchi[SUP] 5 [/SUP], Aoi Miyazaki[SUP] 1 [/SUP], Daiki Naito[SUP] 1 [/SUP], Yuka Tajima[SUP] 1 [/SUP], Hiroshi Takahashi[SUP] 6 [/SUP], Taiyo Komatsu[SUP] 1 [/SUP], Aiko Masunaga[SUP] 1 [/SUP], Hiroto Kishi[SUP] 6 [/SUP], Kazuhiko Fujii[SUP] 6 [/SUP], Koichiro Fukuda[SUP] 6 [/SUP], Yusuke Tomita[SUP] 7 [/SUP], Sho Saeki[SUP] 7 [/SUP], Hidenori Ichiyasu[SUP] 7 [/SUP], Takuro Sakagami[SUP] 7 [/SUP]



Affiliations

Abstract

Background: In December 2019, the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), emerged in Wuhan, China, and has since spread throughout the world. This study aimed to investigate the association between the change in laboratory markers during the three days after pneumonia diagnosis and severe respiratory failure in COVID-19 patients.
Methods: Data of 23 COVID-19 patients with pneumonia, admitted to the Kumamoto City Hospital between February and April 2020 were retrospectively analyzed.
Results: Among the 23 patients, eight patients received mechanical ventilation (MV) (MV group), and the remaining 15 comprised the non-MV group. The levels of hemoglobin (Hb) and albumin (Alb) decreased in the MV group during the three days after pneumonia diagnosis more than in the non-MV group (median Hb: 1.40 vs. -0.10 g/dL, P = 0.015; median Alb: 0.85 vs. -0.30 g/dL, P = 0.020). Univariate logistic regression analysis showed that the decrease in Hb was associated with receiving MV care (odds ratio: 0.313, 95% confidence interval: 0.100-0.976, P = 0.045). Receiver operating characteristic curve analyses showed that the optimal cut-off value for the decrease in Hb level was -1.25 g/dL, with sensitivity and specificity values of 0.867 and 0.750, respectively.
Conclusions: The decrease in Hb level during the short period after pneumonia diagnosis might be a predictor of worsening pneumonia in COVID-19 patients.

Keywords: Albumin; Coronavirus disease 2019; Hemoglobin; Intermittent positive pressure ventilation; Severe acute respiratory syndrome coronavirus-2.
 
Back
Top Bottom